AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2014

Aug 7, 2014

35274_dirs_2014-08-07_1e696698-d7b2-40da-97b3-cc2ddf5ab7e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-08-01

Reporting Person: WESTREICH STANLEY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-01	Common Stock purchase option	$3.01	A	72884	Acquired	2021-08-01	Common Stock (72884)	Direct

Footnotes

F1: Represents compensatory Annual Grant and Committee Grants for director services. The options vest quarterly on 9/30/14, 12/31/14, 3/31/15, and 6/30/15